Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TYMS | P04818 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25516139 | 1.00 | ALDH1A1 (0.48) | ALDH1A1HPGDKDM4EADORA3ADORA1 | |
| SCHEMBL25685719 | 0.96 | ALDH1A1 (0.49) | ALDH1A1HPGDKDM4EADORA3ADORA1 | |
| SCHEMBL25685721 | 0.93 | ALDH1A1 (0.54) | ALDH1A1HPGDKDM4EADORA3ADORA1 | |
| SCHEMBL25685722 | 0.82 | ALDH1A1 (0.38) | ALDH1A1HPGDKDM4EADORA3ADORA1 | |
| SCHEMBL25516142 | 0.81 | ALDH1A1 (0.39) | ALDH1A1HPGDKDM4EADORA3ADORA1 | |
| SCHEMBL25516143 | 0.80 | ALDH1A1 (0.39) | ALDH1A1HPGDKDM4EADORA3ADORA1 | |
| SCHEMBL24840151 | 0.78 | ADORA3 (0.74) | ADORA3ADORA1POLBKMT2A | |
| SCHEMBL25516153 | 0.78 | ADORA3 (0.74) | ADORA3ADORA1POLBKMT2A | |
| SCHEMBL26300002 | 0.76 | ALDH1A1 (0.40) | ALDH1A1HPGDKDM4EADORA3ADORA1 | |
| SCHEMBL26299661 | 0.76 | KDM4E (0.43) | ALDH1A1HPGDKDM4EADORA3ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230200219-A1 | A compound, an organic electroluminescent device and a display device | BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230200219-A1 | A compound, an organic electroluminescent device and a display device | BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD (CN) | 2023-06-22 | — | — | US | disclosed |
| WO-2023093094-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS | 昆山国显光电有限公司 | 2023-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200219-A1 | A compound, an organic electroluminescent device and a display device | L1CAM, VDAC2, CD274 | ALDH1A1 125/4885HPGD 3496/4885KDM4E 2587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.